Delivery Order SPE2DB20D2104-SPE2DB25FMNCZ

Award Date 4/10/25
Potential Completion Date 4/11/25
Potential Value $8.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Velphoro 500 mg chewable tablets. The contract has a ceiling value of $3,940.95 and a completion date of May 15, 2024. It is a firm fixed-price contract and was not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,298.60, is for the delivery of Velphoro 500 mg chewable tablets. This contract does not have a set-aside designation, indicating it was open to full and open competition. The contract is a firm fixed price, delivery order contract that will run through August 25, 2023. AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,913.64 firm-fixed-price contract is for the supply of Velphoro 500 mg chewable tablets, a medication used to treat certain types of kidney disease. The contract has an ultimate completion date of September 24, 2024 and is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $20,827.06, is for the delivery of Velphoro 500 mg chewable tablets. This is a firm fixed-price Delivery Order contract that does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp is for the delivery of Velphoro 500 mg chewable tablets. The contract has a ceiling value of $6,581.47 and a completion date of July 23, 2024. It is a Firm Fixed Price Delivery Order with no set-aside requirements, indicating open competition. AmerisourceBergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $20,822.01, is for the delivery of Velphoro 500 mg chewable tablets. This is a firm-fixed-price delivery order contract with an ultimate completion date of April 9, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,959.99, is a delivery order for the medication Velphoro 500 mg chewable tablets. The contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Velphoro 500 mg chewable tablets. The contract has a ceiling value of $4,489.65 and is for a fixed-price delivery of the pharmaceutical product. The award date is October 15, 2024, and the ultimate completion date is October 16, 2024. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is the prime contractor...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,807.52, is for the delivery of Velphoro 500 mg chewable tablets. The contract has an ultimate completion date of October 31, 2022 and is a firm-fixed-price delivery order. The contract was not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $5,771.86 Firm Fixed Price delivery order is for the supply of 4,565,668,489 units of the pharmaceutical product Velphoro 500 mg Chewable Tablets in 90-count packages. The contract has a completion date of September 4, 2024 and does not have a set-aside designation. AmerisourceBergen is a major pharmaceutical distributor that has been awarded numerous...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMNCZ
    Delivery Order

This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $8,882.86, is for the delivery of Velphoro 500 mg chewable tablets. The contract is a Firm Fixed Price, non-set-aside award with an ultimate completion date of April 11, 2025.

AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This IDC provides a comprehensive global pharmaceutical support vehicle with a performance period through December 2026, enabling the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.

Generated 7/17/25, 6:14 PM